Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

46 (2%)

Anticipated shortage:

1 (0%)

Avoided shortage:

19 (1%)

Resolved:

2226 (97%)

2292

Discontinuation Reports

To be discontinued:

4 (3%)

Discontinued:

119 (95%)

Reversed:

2 (2%)

125

453 (19%)

14 (27%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-08-21 2023-10-17 202544
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-06-09 2022-06-18 162366
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-13 2018-04-19 45809
SANDOZ OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-02-12 2018-08-13 39572
SANDOZ OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-26 2017-11-27 13938
SANDOZ OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-02-12 2018-08-13 39569
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-19 2020-08-24 115328
SANDOZ OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-26 2017-11-06 13935
SANDOZ OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2024-07-08 2024-07-16 232474
SANDOZ OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-07-28 2025-09-03 263635
SANDOZ OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-04 2024-01-03 212451
SANDOZ OLMESARTAN 20MG TABLET Resolved 2024-03-25 2024-05-01 223197
SANDOZ OLMESARTAN 20MG TABLET Resolved 2018-02-05 2018-04-19 38739
SANDOZ OLMESARTAN 40MG TABLET Resolved 2019-04-10 2020-08-24 80944
SANDOZ OLMESARTAN 20MG TABLET Resolved 2019-04-10 2020-08-24 80937
SANDOZ OLMESARTAN 20MG TABLET Resolved 2019-04-10 2020-08-24 80934
SANDOZ OLMESARTAN 20MG TABLET Resolved 2024-06-25 2024-07-03 231209
SANDOZ OLMESARTAN 20MG TABLET Resolved 2024-08-12 2024-11-26 235068
SANDOZ OLMESARTAN 40MG TABLET Resolved 2017-07-24 2017-09-06 16750
SANDOZ OLMESARTAN 40MG TABLET Resolved 2017-09-07 2017-11-13 21291
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000

Showing 1 to 20 of 125